+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
HLA Typing Kit Market by Technology (Next Gen Sequencing, Sanger Sequencing, Sequence Specific Oligonucleotide Probing), Application (Clinical Diagnostics, Disease Association Studies, Organ Transplantation), End User, Product - Global Forecast 2025-2030- Product Image
HLA Typing Kit Market by Technology (Next Gen Sequencing, Sanger Sequencing, Sequence Specific Oligonucleotide Probing), Application (Clinical Diagnostics, Disease Association Studies, Organ Transplantation), End User, Product - Global Forecast 2025-2030- Product Image
New

HLA Typing Kit Market by Technology (Next Gen Sequencing, Sanger Sequencing, Sequence Specific Oligonucleotide Probing), Application (Clinical Diagnostics, Disease Association Studies, Organ Transplantation), End User, Product - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 189 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6139653
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Introduction to the Critical Role of Advanced HLA Typing in Shaping Immunogenetics and Personalized Transplant Medicine Strategies

The landscape of immunogenetics is undergoing a profound evolution, driven by the critical need for precision in human leukocyte antigen (HLA) typing. As healthcare systems worldwide embrace personalized medicine, the ability to accurately characterize HLA variants has become a cornerstone for optimizing transplant compatibility, advancing disease association studies, and refining immunotherapy protocols. This executive summary introduces the pivotal role that advanced HLA typing methodologies play in reducing graft rejection rates, enhancing patient outcomes, and accelerating research breakthroughs.

In this introduction, we outline the fundamental concepts and contextualize the significance of emerging sequencing and assay technologies in the HLA typing arena. By framing the discussion within the broader trends of genomics democratization and precision diagnostics, we set the stage for a deep dive into transformative shifts, tariff implications, segmentation complexities, regional dynamics, and competitive strategies. Through this structured narrative, decision-makers will gain clarity on how state-of-the-art HLA typing solutions are reshaping clinical workflows and research paradigms, ultimately supporting more informed investment and partnership decisions.

Exploring Transformative Technological and Regulatory Shifts Redefining Precision in HLA Typing and Diagnostics for Immunogenetics Applications

The HLA typing landscape is characterized by relentless technological innovation and evolving regulatory frameworks. Recent years have witnessed the transition from traditional Sanger Sequencing toward next-generation platforms, enabling higher throughput and resolution. Concurrently, sequence-specific oligonucleotide probing and primer-based approaches have introduced cost-effective alternatives for targeted allele discrimination. These methodological advancements have been paralleled by stringent validation guidelines and quality standards instituted by international regulatory authorities, ensuring assay reliability and patient safety.

Moreover, the integration of bioinformatics pipelines and data analytics tools has elevated the interpretive power of raw sequencing reads, allowing laboratories to decipher complex haplotypes and novel alleles with greater confidence. Consequently, stakeholders in both clinical and research settings must adapt to these paradigm shifts by investing in cross-functional expertise, infrastructure upgrades, and robust validation processes. This section explores how the convergence of technological refinement and regulatory oversight is redefining the benchmarks of accuracy, reproducibility, and scalability in HLA typing.

Assessing the Cumulative Impact of United States Tariff Adjustments on International HLA Typing Supply Chains and Market Accessibility Dynamics

In 2025, policy revisions introduced a new tranche of U.S. tariffs affecting imported molecular diagnostics components, including reagents, instruments, and consumables essential for HLA typing workflows. These tariff adjustments have triggered a ripple effect across global supply chains, prompting end users and manufacturers to reexamine sourcing strategies and cost structures. As import duties rise, laboratories dependent on overseas suppliers face potential margin pressures, while domestic producers encounter both opportunities for market penetration and challenges in scaling production rapidly.

Furthermore, the tariff landscape has catalyzed strategic realignments, with some diagnostic companies diversifying their manufacturing footprint to jurisdictions unaffected by the levies. In addition, collaborative partnerships have emerged as a mechanism to mitigate supply disruptions, leveraging local contract manufacturers and reagent distributors to maintain continuity of service. This section assesses how cumulative tariff impacts are reshaping procurement decisions, investment priorities, and cross-border alliances, ultimately influencing the accessibility and affordability of HLA typing solutions.

Uncovering Key Segmentation Insights Across Technology Platforms Applications End Users and Product Categories Driving HLA Typing Market Complexity

A nuanced segmentation analysis reveals the multifaceted drivers behind HLA typing adoption. Technologically, the market is anchored by high-resolution techniques such as next generation sequencing, which itself encompasses amplicon sequencing for targeted loci studies, targeted sequencing for panels of clinical relevance, and whole genome sequencing for comprehensive immunogenetic profiling. Complementing these are established Sanger sequencing protocols, sequence specific oligonucleotide probing for allele-specific detection, and sequence specific primer assays that balance cost efficiency with diagnostic precision.

Application-wise, HLA typing underpins clinical diagnostics for autoimmune disorder screening and HLA-linked disease association studies, while serving critical roles in organ transplantation contexts-spanning both pre-transplant screening to evaluate donor-recipient compatibility and post-transplant monitoring to detect potential rejection markers. Research applications further leverage these modalities to explore immunogenetics and population diversity.

From an end user perspective, diagnostic laboratories-including both commercial and hospital-based facilities-constitute the primary demand centers, supported by hospitals and clinics in community and academic settings. Research institutes pursuing academic and translational studies, together with specialized transplant centers focusing on heart, kidney, and liver graft programs, complete the landscape. Finally, product segmentation spans capital instrumentation such as PCR thermocyclers, reagent dispensers, and high-throughput sequencers; consumable kits ranging from multiplex to single-test formats; reagents including enzymes, primers, probes, and sequencing chemistries; and bioinformatics services paired with data analysis software. Each segment contributes unique value propositions, prescribing differentiated adoption strategies and ROI profiles.

Key Regional Perspectives on Demand Growth Infrastructure Capabilities and Adoption Patterns for HLA Typing Across the Americas EMEA and Asia-Pacific

Regional market dynamics underscore significant variations in adoption, infrastructure maturity, and policy environments. In the Americas, robust transplant programs and well-established diagnostic laboratory networks have driven early uptake of advanced HLA typing platforms. North American institutions benefit from extensive reimbursement frameworks and collaborative research consortia, enabling rapid technology validation and deployment.

Shifting focus to Europe, Middle East, and Africa, diverse healthcare system structures and regulatory landscapes present both challenges and opportunities. While Western European countries exhibit mature genomics initiatives and harmonized quality standards, emerging markets in the Middle East and Africa are investing in diagnostic capacity-building and public-private partnerships to address organ transplant demand and disease surveillance needs.

Across Asia-Pacific, population diversity and a growing emphasis on precision medicine have catalyzed significant investments in both public and private laboratory infrastructures. Countries such as Japan, China, and Australia lead in technology adoption, supported by government funding and academic collaborations, whereas Southeast Asian and South Asian regions are gradually expanding their diagnostic pipelines through capacity enhancement and training programs. These divergent regional trajectories inform targeted market entry and expansion strategies.

Analyzing Leading Industry Players Innovations Collaborations and Strategic Developments Shaping Competitive Dynamics in the Global HLA Typing Landscape

Leading organizations in the HLA typing space have demonstrated dynamic strategies to secure competitive advantages. Thermo Fisher Scientific has expanded its portfolio with integrated next generation sequencing kits and automation solutions, partnering with academic centers to validate ultra-high-resolution haplotyping workflows. Illumina continues to refine its sequencing by synthesis platforms, introducing novel library preparation chemistries to accelerate throughput and reduce hands-on time.

QIAGEN has strengthened its presence in the sequence specific oligonucleotide and primer segment by launching multiplex assay kits optimized for organ transplantation screening, while investing in digital PCR enhancements for sensitive allele quantification. In parallel, specialized players such as HistoGenetics have carved out niche expertise in bioinformatics services, collaborating with software providers to deliver end-to-end analytics pipelines tailored to complex HLA datasets.

Furthermore, strategic alliances among reagent manufacturers, instrument providers, and informatics firms have generated comprehensive solution bundles, enabling customers to leverage turnkey offerings. Merger and acquisition activity has also intensified, as firms seek to broaden their technological capabilities and geographic reach. This competitive interplay underscores the importance of continuous innovation, strategic partnerships, and operational scalability in driving long-term success in the HLA typing market.

Actionable Strategic Recommendations for Industry Leaders to Enhance Market Positioning and Drive Operational Excellence in HLA Typing Solutions

To maintain a leadership position, stakeholders should prioritize the integration of advanced automation and artificial intelligence-driven analytics to reduce turnaround times and enhance allele calling accuracy. Investing in modular workflows that allow seamless transitions between targeted panels and whole genome approaches will cater to diverse application needs while optimizing resource utilization. Moreover, establishing strategic partnerships with regional contract manufacturers can mitigate tariff-induced margin pressures and fortify supply chain resilience.

In addition, forging collaborative research agreements with academic institutions and transplant centers will accelerate validation studies and support evidence generation for novel assay adoption. Stakeholders are also encouraged to develop comprehensive training and certification programs for laboratory personnel, ensuring consistent quality control and regulatory compliance. Lastly, diversifying service offerings by bundling bioinformatics services with reagent and instrument sales can unlock recurring revenue streams and foster customer loyalty. Implementing these actionable strategies will enable industry leaders to navigate market complexities and capitalize on emerging growth opportunities.

Rigorous Research Methodology Combining Primary Interviews Secondary Data Analysis and Advanced Statistical Techniques to Ensure Robust HLA Typing Insights

This study employs a rigorous research methodology, commencing with extensive secondary data collection from peer-reviewed journals, regulatory agency publications, and industry archives to establish a comprehensive contextual baseline. Subsequently, primary interviews were conducted with senior executives, laboratory directors, and key opinion leaders across major geographic regions to validate insights and capture real-world implementation challenges.

Quantitative data analysis involved the aggregation of procurement and usage patterns, while statistical trends were corroborated through expert panels to ensure interpretive accuracy. The research design also incorporated comparative assessments of technology performance metrics, regulatory approval timelines, and competitive intelligence to delineate strategic landscapes. Additionally, sensitivity analyses were applied to evaluate the robustness of observed shifts in supply chain configurations under varying tariff scenarios.

By integrating qualitative perspectives with quantitative rigor and employing advanced statistical techniques, this methodological framework ensures that the insights presented are both evidence-based and actionable for stakeholders seeking to understand and influence the trajectory of HLA typing advancement.

Conclusion Synthesizing Key Findings and Strategic Imperatives Guiding Future Innovations Investments and Collaborative Opportunities in HLA Typing

This executive summary synthesizes the pivotal themes shaping the future of HLA typing: the emergence of cutting-edge sequencing and assay technologies, the transformative effect of international tariff policies, the intricate segmentation across technology, application, end user, and product domains, and the diverse regional maturation trajectories. Moreover, it highlights how major industry players are leveraging innovation, partnerships, and strategic expansions to secure market leadership.

Collectively, these insights underscore the criticality of adopting a holistic approach that balances technological adoption with supply chain agility and regulatory preparedness. By aligning strategic investments with evolving clinical and research imperatives, stakeholders can optimize diagnostic precision, improve patient outcomes, and sustain long-term growth. As the HLA typing ecosystem continues to mature, proactive collaboration and data-driven decision-making will be paramount in unlocking the next wave of immunogenetics breakthroughs.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Technology
    • Next Gen Sequencing
      • Amplicon Sequencing
      • Targeted Sequencing
      • Whole Genome Sequencing
    • Sanger Sequencing
    • Sequence Specific Oligonucleotide Probing
    • Sequence Specific Primer
  • Application
    • Clinical Diagnostics
    • Disease Association Studies
    • Organ Transplantation
      • Post Transplant Monitoring
      • Pre Transplant Screening
    • Research
  • End User
    • Diagnostic Laboratories
      • Commercial Laboratories
      • Hospital Laboratories
    • Hospitals & Clinics
      • Community Hospitals
      • University Hospitals
    • Research Institutes
    • Transplant Centers
      • Heart Transplant Centers
      • Kidney Transplant Centers
      • Liver Transplant Centers
  • Product
    • Instruments
      • PCR Thermocyclers
      • Reagent Dispensers
      • Sequencers
    • Kits
      • Multiplex Kits
      • Single Test Kits
    • Reagents
      • Enzymes
      • Primers
      • Probes
      • Sequencing Reagents
    • Software & Services
      • Bioinformatics Services
      • Data Analysis Software
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • Thermo Fisher Scientific, Inc.
  • Immucor, Inc.
  • Bio-Rad Laboratories, Inc.
  • QIAGEN N.V.
  • GenDx B.V.
  • Illumina, Inc.
  • Roche Holding AG
  • BGI Genomics Co., Ltd.
  • Abbott Laboratories
  • DiaSorin S.p.A.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of high throughput NGS technology in HLA typing kits to reduce turnaround time
5.2. Adoption of automated microfluidic platforms for streamlined HLA allele sequencing workflows
5.3. Emergence of combinatorial PCR primer sets for high fidelity HLA locus coverage and specificity
5.4. Increasing regulatory approvals of in vitro diagnostic HLA typing kits across emerging markets
5.5. Rising demand for ultra high resolution HLA typing in personalized transplant compatibility testing
5.6. Integration of artificial intelligence algorithms for enhanced HLA allele calling accuracy in kit software
5.7. Strategic partnerships between HLA kit manufacturers and genomic data analytics firms to expand offerings
5.8. Growing focus on cost effective single antigen bead panels for rapid HLA antibody screening in clinics
5.9. Launch of multiplexed HLA typing kits compatible with portable point of care diagnostic devices
5.10. R&D investment in CRISPR based HLA gene editing techniques to develop next generation typing reagents
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. HLA Typing Kit Market, by Technology
8.1. Introduction
8.2. Next Gen Sequencing
8.2.1. Amplicon Sequencing
8.2.2. Targeted Sequencing
8.2.3. Whole Genome Sequencing
8.3. Sanger Sequencing
8.4. Sequence Specific Oligonucleotide Probing
8.5. Sequence Specific Primer
9. HLA Typing Kit Market, by Application
9.1. Introduction
9.2. Clinical Diagnostics
9.3. Disease Association Studies
9.4. Organ Transplantation
9.4.1. Post Transplant Monitoring
9.4.2. Pre Transplant Screening
9.5. Research
10. HLA Typing Kit Market, by End User
10.1. Introduction
10.2. Diagnostic Laboratories
10.2.1. Commercial Laboratories
10.2.2. Hospital Laboratories
10.3. Hospitals & Clinics
10.3.1. Community Hospitals
10.3.2. University Hospitals
10.4. Research Institutes
10.5. Transplant Centers
10.5.1. Heart Transplant Centers
10.5.2. Kidney Transplant Centers
10.5.3. Liver Transplant Centers
11. HLA Typing Kit Market, by Product
11.1. Introduction
11.2. Instruments
11.2.1. PCR Thermocyclers
11.2.2. Reagent Dispensers
11.2.3. Sequencers
11.3. Kits
11.3.1. Multiplex Kits
11.3.2. Single Test Kits
11.4. Reagents
11.4.1. Enzymes
11.4.2. Primers
11.4.3. Probes
11.4.4. Sequencing Reagents
11.5. Software & Services
11.5.1. Bioinformatics Services
11.5.2. Data Analysis Software
12. Americas HLA Typing Kit Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa HLA Typing Kit Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific HLA Typing Kit Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Thermo Fisher Scientific, Inc.
15.3.2. Immucor, Inc.
15.3.3. Bio-Rad Laboratories, Inc.
15.3.4. QIAGEN N.V.
15.3.5. GenDx B.V.
15.3.6. Illumina, Inc.
15.3.7. Roche Holding AG
15.3.8. BGI Genomics Co., Ltd.
15.3.9. Abbott Laboratories
15.3.10. DiaSorin S.p.A.
16. Research AI17. Research Statistics18. Research Contacts19. Research Articles20. Appendix
List of Figures
FIGURE 1. HLA TYPING KIT MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL HLA TYPING KIT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL HLA TYPING KIT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL HLA TYPING KIT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL HLA TYPING KIT MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 6. GLOBAL HLA TYPING KIT MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL HLA TYPING KIT MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL HLA TYPING KIT MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL HLA TYPING KIT MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL HLA TYPING KIT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL HLA TYPING KIT MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
FIGURE 12. GLOBAL HLA TYPING KIT MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS HLA TYPING KIT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS HLA TYPING KIT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES HLA TYPING KIT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES HLA TYPING KIT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA HLA TYPING KIT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA HLA TYPING KIT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC HLA TYPING KIT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC HLA TYPING KIT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. HLA TYPING KIT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. HLA TYPING KIT MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. HLA TYPING KIT MARKET: RESEARCHAI
FIGURE 24. HLA TYPING KIT MARKET: RESEARCHSTATISTICS
FIGURE 25. HLA TYPING KIT MARKET: RESEARCHCONTACTS
FIGURE 26. HLA TYPING KIT MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. HLA TYPING KIT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL HLA TYPING KIT MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL HLA TYPING KIT MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL HLA TYPING KIT MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL HLA TYPING KIT MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL HLA TYPING KIT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL HLA TYPING KIT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL HLA TYPING KIT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL HLA TYPING KIT MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL HLA TYPING KIT MARKET SIZE, BY NEXT GEN SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL HLA TYPING KIT MARKET SIZE, BY NEXT GEN SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL HLA TYPING KIT MARKET SIZE, BY AMPLICON SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL HLA TYPING KIT MARKET SIZE, BY AMPLICON SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL HLA TYPING KIT MARKET SIZE, BY TARGETED SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL HLA TYPING KIT MARKET SIZE, BY TARGETED SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL HLA TYPING KIT MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL HLA TYPING KIT MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL HLA TYPING KIT MARKET SIZE, BY NEXT GEN SEQUENCING, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL HLA TYPING KIT MARKET SIZE, BY NEXT GEN SEQUENCING, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL HLA TYPING KIT MARKET SIZE, BY SANGER SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL HLA TYPING KIT MARKET SIZE, BY SANGER SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL HLA TYPING KIT MARKET SIZE, BY SEQUENCE SPECIFIC OLIGONUCLEOTIDE PROBING, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL HLA TYPING KIT MARKET SIZE, BY SEQUENCE SPECIFIC OLIGONUCLEOTIDE PROBING, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL HLA TYPING KIT MARKET SIZE, BY SEQUENCE SPECIFIC PRIMER, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL HLA TYPING KIT MARKET SIZE, BY SEQUENCE SPECIFIC PRIMER, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL HLA TYPING KIT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL HLA TYPING KIT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL HLA TYPING KIT MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL HLA TYPING KIT MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL HLA TYPING KIT MARKET SIZE, BY DISEASE ASSOCIATION STUDIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL HLA TYPING KIT MARKET SIZE, BY DISEASE ASSOCIATION STUDIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL HLA TYPING KIT MARKET SIZE, BY ORGAN TRANSPLANTATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL HLA TYPING KIT MARKET SIZE, BY ORGAN TRANSPLANTATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL HLA TYPING KIT MARKET SIZE, BY POST TRANSPLANT MONITORING, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL HLA TYPING KIT MARKET SIZE, BY POST TRANSPLANT MONITORING, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL HLA TYPING KIT MARKET SIZE, BY PRE TRANSPLANT SCREENING, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL HLA TYPING KIT MARKET SIZE, BY PRE TRANSPLANT SCREENING, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL HLA TYPING KIT MARKET SIZE, BY ORGAN TRANSPLANTATION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL HLA TYPING KIT MARKET SIZE, BY ORGAN TRANSPLANTATION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL HLA TYPING KIT MARKET SIZE, BY RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL HLA TYPING KIT MARKET SIZE, BY RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL HLA TYPING KIT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL HLA TYPING KIT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL HLA TYPING KIT MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL HLA TYPING KIT MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL HLA TYPING KIT MARKET SIZE, BY COMMERCIAL LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL HLA TYPING KIT MARKET SIZE, BY COMMERCIAL LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL HLA TYPING KIT MARKET SIZE, BY HOSPITAL LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL HLA TYPING KIT MARKET SIZE, BY HOSPITAL LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL HLA TYPING KIT MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL HLA TYPING KIT MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL HLA TYPING KIT MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL HLA TYPING KIT MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL HLA TYPING KIT MARKET SIZE, BY COMMUNITY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL HLA TYPING KIT MARKET SIZE, BY COMMUNITY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL HLA TYPING KIT MARKET SIZE, BY UNIVERSITY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL HLA TYPING KIT MARKET SIZE, BY UNIVERSITY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL HLA TYPING KIT MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL HLA TYPING KIT MARKET SIZE, BY HOSPITALS & CLINICS, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL HLA TYPING KIT MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL HLA TYPING KIT MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL HLA TYPING KIT MARKET SIZE, BY TRANSPLANT CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL HLA TYPING KIT MARKET SIZE, BY TRANSPLANT CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL HLA TYPING KIT MARKET SIZE, BY HEART TRANSPLANT CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL HLA TYPING KIT MARKET SIZE, BY HEART TRANSPLANT CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL HLA TYPING KIT MARKET SIZE, BY KIDNEY TRANSPLANT CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL HLA TYPING KIT MARKET SIZE, BY KIDNEY TRANSPLANT CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL HLA TYPING KIT MARKET SIZE, BY LIVER TRANSPLANT CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL HLA TYPING KIT MARKET SIZE, BY LIVER TRANSPLANT CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL HLA TYPING KIT MARKET SIZE, BY TRANSPLANT CENTERS, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL HLA TYPING KIT MARKET SIZE, BY TRANSPLANT CENTERS, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL HLA TYPING KIT MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL HLA TYPING KIT MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL HLA TYPING KIT MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL HLA TYPING KIT MARKET SIZE, BY INSTRUMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL HLA TYPING KIT MARKET SIZE, BY PCR THERMOCYCLERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL HLA TYPING KIT MARKET SIZE, BY PCR THERMOCYCLERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL HLA TYPING KIT MARKET SIZE, BY REAGENT DISPENSERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL HLA TYPING KIT MARKET SIZE, BY REAGENT DISPENSERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL HLA TYPING KIT MARKET SIZE, BY SEQUENCERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL HLA TYPING KIT MARKET SIZE, BY SEQUENCERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL HLA TYPING KIT MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL HLA TYPING KIT MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL HLA TYPING KIT MARKET SIZE, BY KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL HLA TYPING KIT MARKET SIZE, BY KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL HLA TYPING KIT MARKET SIZE, BY MULTIPLEX KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL HLA TYPING KIT MARKET SIZE, BY MULTIPLEX KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL HLA TYPING KIT MARKET SIZE, BY SINGLE TEST KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL HLA TYPING KIT MARKET SIZE, BY SINGLE TEST KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL HLA TYPING KIT MARKET SIZE, BY KITS, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL HLA TYPING KIT MARKET SIZE, BY KITS, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL HLA TYPING KIT MARKET SIZE, BY REAGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL HLA TYPING KIT MARKET SIZE, BY REAGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL HLA TYPING KIT MARKET SIZE, BY ENZYMES, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL HLA TYPING KIT MARKET SIZE, BY ENZYMES, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL HLA TYPING KIT MARKET SIZE, BY PRIMERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL HLA TYPING KIT MARKET SIZE, BY PRIMERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL HLA TYPING KIT MARKET SIZE, BY PROBES, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL HLA TYPING KIT MARKET SIZE, BY PROBES, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL HLA TYPING KIT MARKET SIZE, BY SEQUENCING REAGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL HLA TYPING KIT MARKET SIZE, BY SEQUENCING REAGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL HLA TYPING KIT MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL HLA TYPING KIT MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL HLA TYPING KIT MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL HLA TYPING KIT MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL HLA TYPING KIT MARKET SIZE, BY BIOINFORMATICS SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL HLA TYPING KIT MARKET SIZE, BY BIOINFORMATICS SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL HLA TYPING KIT MARKET SIZE, BY DATA ANALYSIS SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL HLA TYPING KIT MARKET SIZE, BY DATA ANALYSIS SOFTWARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL HLA TYPING KIT MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL HLA TYPING KIT MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS HLA TYPING KIT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS HLA TYPING KIT MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS HLA TYPING KIT MARKET SIZE, BY NEXT GEN SEQUENCING, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS HLA TYPING KIT MARKET SIZE, BY NEXT GEN SEQUENCING, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS HLA TYPING KIT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS HLA TYPING KIT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS HLA TYPING KIT MARKET SIZE, BY ORGAN TRANSPLANTATION, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS HLA TYPING KIT MARKET SIZE, BY ORGAN TRANSPLANTATION, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS HLA TYPING KIT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS HLA TYPING KIT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS HLA TYPING KIT MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS HLA TYPING KIT MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS HLA TYPING KIT MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS HLA TYPING KIT MARKET SIZE, BY HOSPITALS & CLINICS, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS HLA TYPING KIT MARKET SIZE, BY TRANSPLANT CENTERS, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS HLA TYPING KIT MARKET SIZE, BY TRANSPLANT CENTERS, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS HLA TYPING KIT MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS HLA TYPING KIT MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 131. AMERICAS HLA TYPING KIT MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 132. AMERICAS HLA TYPING KIT MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 133. AMERICAS HLA TYPING KIT MARKET SIZE, BY KITS, 2018-2024 (USD MILLION)
TABLE 134. AMERICAS HLA TYPING KIT MARKET SIZE, BY KITS, 2025-2030 (USD MILLION)
TABLE 135. AMERICAS HLA TYPING KIT MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 136. AMERICAS HLA TYPING KIT MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 137. AMERICAS HLA TYPING KIT MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
TABLE 138. AMERICAS HLA TYPING KIT MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2030 (USD MILLION)
TABLE 139. AMERICAS HLA TYPING KIT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 140. AMERICAS HLA TYPING KIT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES HLA TYPING KIT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES HLA TYPING KIT MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES HLA TYPING KIT MARKET SIZE, BY NEXT GEN SEQUENCING, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES HLA TYPING KIT MARKET SIZE, BY NEXT GEN SEQUENCING, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES HLA TYPING KIT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES HLA TYPING KIT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 147. UNITED STATES HLA TYPING KIT MARKET SIZE, BY ORGAN TRANSPLANTATION, 2018-2024 (USD MILLION)
TABLE 148. UNITED STATES HLA TYPING KIT MARKET SIZE, BY ORGAN TRANSPLANTATION, 2025-2030 (USD MILLION)
TABLE 149. UNITED STATES HLA TYPING KIT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 150. UNITED STATES HLA TYPING KIT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 151. UNITED STATES HLA TYPING KIT MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 152. UNITED STATES HLA TYPING KIT MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 153. UNITED STATES HLA TYPING KIT MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2024 (USD MILLION)
TABLE 154. UNITED STATES HLA TYPING KIT MARKET SIZE, BY HOSPITALS & CLINICS, 2025-2030 (USD MILLION)
TABLE 155. UNITED STATES HLA TYPING KIT MARKET SIZE, BY TRANSPLANT CENTERS, 2018-2024 (USD MILLION)
TABLE 156. UNITED STATES HLA TYPING KIT MARKET SIZE, BY TRANSPLANT CENTERS, 2025-2030 (USD MILLION)
TABLE 157. UNITED STATES HLA TYPING KIT MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 158. UNITED STATES HLA TYPING KIT MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 159. UNITED STATES HLA TYPING KIT MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 160. UNITED STATES HLA TYPING KIT MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 161. UNITED STATES HLA TYPING KIT MARKET SIZE, BY KITS, 2018-2024 (USD MILLION)
TABLE 162. UNITED STATES HLA TYPING KIT MARKET SIZE, BY KITS, 2025-2030 (USD MILLION)
TABLE 163. UNITED STATES HLA TYPING KIT MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 164. UNITED STATES HLA TYPING KIT MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 165. UNITED STATES HLA TYPING KIT MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
TABLE 166. UNITED STATES HLA TYPING KIT MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2030 (USD MILLION)
TABLE 167. UNITED STATES HLA TYPING KIT MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 168. UNITED STATES HLA TYPING KIT MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 169. CANADA HLA TYPING KIT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 170. CANADA HLA TYPING KIT MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 171. CANADA HLA TYPING KIT MARKET SIZE, BY NEXT GEN SEQUENCING, 2018-2024 (USD MILLION)
TABLE 172. CANADA HLA TYPING KIT MARKET SIZE, BY NEXT GEN SEQUENCING, 2025-2030 (USD MILLION)
TABLE 173. CANADA HLA TYPING KIT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 174. CANADA HLA TYPING KIT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 175. CANADA HLA TYPING KIT MARKET SIZE, BY ORGAN TRANSPLANTATION, 2018-2024 (USD MILLION)
TABLE 176. CANADA HLA TYPING KIT MARKET SIZE, BY ORGAN TRANSPLANTATION, 2025-2030 (USD MILLION)
TABLE 177. CANADA HLA TYPING KIT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 178. CANADA HLA TYPING KIT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 179. CANADA HLA TYPING KIT MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 180. CANADA HLA TYPING KIT MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 181. CANADA HLA TYPING KIT MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2024 (USD MILLION)
TABLE 182. CANADA HLA TYPING KIT MARKET SIZE, BY HOSPITALS & CLINICS, 2025-2030 (USD MILLION)
TABLE 183. CANADA HLA TYPING KIT MARKET SIZE, BY TRANSPLANT CENTERS, 2018-2024 (USD MILLION)
TABLE 184. CANADA HLA TYPING KIT MARKET SIZE, BY TRANSPLANT CENTERS, 2025-2030 (USD MILLION)
TABLE 185. CANADA HLA TYPING KIT MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 186. CANADA HLA TYPING KIT MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 187. CANADA HLA TYPING KIT MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 188. CANADA HLA TYPING KIT MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 189. CANADA HLA TYPING KIT MARKET SIZE, BY KITS, 2018-2024 (USD MILLION)
TABLE 190. CANADA HLA TYPING KIT MARKET SIZE, BY KITS, 2025-2030 (USD MILLION)
TABLE 191. CANADA HLA TYPING KIT MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 192. CANADA HLA TYPING KIT MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 193. CANADA HLA TYPING KIT MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
TABLE 194. CANADA HLA TYPING KIT MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2030 (USD MILLION)
TABLE 195. MEXICO HLA TYPING KIT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 196. MEXICO HLA TYPING KIT MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 197. MEXICO HLA TYPING KIT MARKET SIZE, BY NEXT GEN SEQUENCING, 2018-2024 (USD MILLION)
TABLE 198. MEXICO HLA TYPING KIT MARKET SIZE, BY NEXT GEN SEQUENCING, 2025-2030 (USD MILLION)
TABLE 199. MEXICO HLA TYPING KIT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 200. MEXICO HLA TYPING KIT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 201. MEXICO HLA TYPING KIT MARKET SIZE, BY ORGAN TRANSPLANTATION, 2018-2024 (USD MILLION)
TABLE 202. MEXICO HLA TYPING KIT MARKET SIZE, BY ORGAN TRANSPLANTATION, 2025-2030 (USD MILLION)
TABLE 203. MEXICO HLA TYPING KIT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 204. MEXICO HLA TYPING KIT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 205. MEXICO HLA TYPING KIT MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 206. MEXICO HLA TYPING KIT MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 207. MEXICO HLA TYPING KIT MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2024 (USD MILLION)
TABLE 208. MEXICO HLA TYPING KIT MARKET SIZE, BY HOSPITALS & CLINICS, 2025-2030 (USD MILLION)
TABLE 209. MEXICO HLA TYPING KIT MARKET SIZE, BY TRANSPLANT CENTERS, 2018-2024 (USD MILLION)
TABLE 210. MEXICO HLA TYPING KIT MARKET SIZE, BY TRANSPLANT CENTERS, 2025-2030 (USD MILLION)
TABLE 211. MEXICO HLA TYPING KIT MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 212. MEXICO HLA TYPING KIT MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 213. MEXICO HLA TYPING KIT MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 214. MEXICO HLA TYPING KIT MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 215. MEXICO HLA TYPING KIT MARKET SIZE, BY KITS, 2018-2024 (USD MILLION)
TABLE 216. MEXICO HLA TYPING KIT MARKET SIZE, BY KITS, 2025-2030 (USD MILLION)
TABLE 217. MEXICO HLA TYPING KIT MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 218. MEXICO HLA TYPING KIT MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 219. MEXICO HLA TYPING KIT MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
TABLE 220. MEXICO HLA TYPING KIT MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2030 (USD MILLION)
TABLE 221. BRAZIL HLA TYPING KIT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 222. BRAZIL HLA TYPING KIT MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 223. BRAZIL HLA TYPING KIT MARKET SIZE, BY NEXT GEN SEQUENCING, 2018-2024 (USD MILLION)
TABLE 224. BRAZIL HLA TYPING KIT MARKET SIZE, BY NEXT GEN SEQUENCING, 2025-2030 (USD MILLION)
TABLE 225. BRAZIL HLA TYPING KIT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 226. BRAZIL HLA TYPING KIT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 227. BRAZIL HLA TYPING KIT MARKET SIZE, BY ORGAN TRANSPLANTATION, 2018-2024 (USD MILLION)
TABLE 228. BRAZIL HLA TYPING KIT MARKET SIZE, BY ORGAN TRANSPLANTATION, 2025-2030 (USD MILLION)
TABLE 229. BRAZIL HLA TYPING KIT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 230. BRAZIL HLA TYPING KIT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 231. BRAZIL HLA TYPING KIT MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 232. BRAZIL HLA TYPING KIT MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 233. BRAZIL HLA TYPING KIT MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2024 (USD MILLION)
TABLE 234. BRAZIL HLA TYPING KIT MARKET SIZE, BY HOSPITALS & CLINICS, 2025-2030 (USD MILLION)
TABLE 235. BRAZIL HLA TYPING KIT MARKET SIZE, BY TRANSPLANT CENTERS, 2018-2024 (USD MILLION)
TABLE 236. BRAZIL HLA TYPING KIT MARKET SIZE, BY TRANSPLANT CENTERS, 2025-2030 (USD MILLION)
TABLE 237. BRAZIL HLA TYPING KIT MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 238. BRAZIL HLA TYPING KIT MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 239. BRAZIL HLA TYPING KIT MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 240. BRAZIL HLA TYPING KIT MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 241. BRAZIL HLA TYPING KIT MARKET SIZE, BY KITS, 2018-2024 (USD MILLION)
TABLE 242. BRAZIL HLA TYPING KIT MARKET SIZE, BY KITS, 2025-2030 (USD MILLION)
TABLE 243. BRAZIL HLA TYPING KIT MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 244. BRAZIL HLA TYPING KIT MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 245. BRAZIL HLA TYPING KIT MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
TABLE 246. BRAZIL HLA TYPING KIT MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2030 (USD MILLION)
TABLE 247. ARGENTINA HLA TYPING KIT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 248. ARGENTINA HLA TYPING KIT MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 249. ARGENTINA HLA TYPING KIT MARKET SIZE, BY NEXT GEN SEQUENCING, 2018-2024 (USD MILLION)
TABLE 250. ARGENTINA HLA TYPING KIT MARKET SIZE, BY NEXT GEN SEQUENCING, 2025-2030 (USD MILLION)
TABLE 251. ARGENTINA HLA TYPING KIT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 252. ARGENTINA HLA TYPING KIT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 253. ARGENTINA HLA TYPING KIT MARKET SIZE, BY ORGAN TRANSPLANTATION, 2018-2024 (USD MILLION)
TABLE 254. ARGENTINA HLA TYPING KIT MARKET SIZE, BY ORGAN TRANSPLANTATION, 2025-2030 (USD MILLION)
TABLE 255. ARGENTINA HLA TYPING KIT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 256. ARGENTINA HLA TYPING KIT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 257. ARGENTINA HLA TYPING KIT MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 258. ARGENTINA HLA TYPING KIT MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 259. ARGENTINA HLA TYPING KIT MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2024 (USD MILLION)
TABLE 260. ARGENTINA HLA TYPING KIT MARKET SIZE, BY HOSPITALS & CLINICS, 2025-2030 (USD MILLION)
TABLE 261. ARGENTINA HLA TYPING KIT MARKET SIZE, BY TRANSPLANT CENTERS, 2018-2024 (USD MILLION)
TABLE 262. ARGENTINA HLA TYPING KIT MARKET SIZE, BY TRANSPLANT CENTERS, 2025-2030 (USD MILLION)
TABLE 263. ARGENTINA HLA TYPING KIT MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 264. ARGENTINA HLA TYPING KIT MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 265. ARGENTINA HLA TYPING KIT MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 266. ARGENTINA HLA TYPING KIT MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 267. ARGENTINA HLA TYPING KIT MARKET SIZE, BY KITS, 2018-2024 (USD MILLION)
TABLE 268. ARGENTINA HLA TYPING KIT MARKET SIZE, BY KITS, 2025-2030 (USD MILLION)
TABLE 269. ARGENTINA HLA TYPING KIT MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 270. ARGENTINA HLA TYPING KIT MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 271. ARGENTINA HLA TYPING KIT MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
TABLE 272. ARGENTINA HLA TYPING KIT MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2030 (USD MILLION)
TABLE 273. EUROPE, MIDDLE EAST & AFRICA HLA TYPING KIT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 274. EUROPE, MIDDLE EAST & AFRICA HLA TYPING KIT MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 275. EUROPE, MIDDLE EAST & AFRICA HLA TYPING KIT MARKET SIZE, BY NEXT GEN SEQUENCING, 2018-2024 (USD MILLION)
TABLE 276. EUROPE, MIDDLE EAST & AFRICA HLA TYPING KIT MARKET SIZE, BY NEXT GEN SEQUENCING, 2025-2030 (USD MILLION)
TABLE 277. EUROPE, MIDDLE EAST & AFRICA HLA TYPING KIT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 278. EUROPE, MIDDLE EAST & AFRICA HLA TYPING KIT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 279. EUROPE, MIDDLE EAST & AFRICA HLA TYPING KIT MARKET SIZE, BY ORGAN TRANSPLANTATION, 2018-2024 (USD MILLION)
TABLE 280. EUROPE, MIDDLE EAST & AFRICA HLA TYPING KIT MARKET SIZE, BY ORGAN TRANSPLANTATION, 2025-2030 (USD MILLION)
TABLE 281. EUROPE, MIDDLE EAST & AFRICA HLA TYPING KIT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 282. EUROPE, MIDDLE EAST & AFRICA HLA TYPING KIT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 283. EUROPE, MIDDLE EAST & AFRICA HLA TYPING KIT MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 284. EUROPE, MIDDLE EAST & AFRICA HLA TYPING KIT MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 285. EUROPE, MIDDLE EAST & AFRICA HLA TYPING KIT MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2024 (USD MILLION)
TABLE 286. EUROPE, MIDDLE EAST & AFRICA HLA TYPING KIT MARKET SIZE, BY HOSPITALS & CLINICS, 2025-2030 (USD MILLION)
TABLE 287. EUROPE, MIDDLE EAST & AFRICA HLA TYPING KIT MARKET SIZE, BY TRANSPLANT CENTERS, 2018-2024 (USD MILLION)
TABLE 288. EUROPE, MIDDLE EAST & AFRICA HLA TYPING KIT MARKET SIZE, BY TRANSPLANT CENTERS, 2025-2030 (USD MILLION)
TABLE 289. EUROPE, MIDDLE EAST & AFRICA HLA TYPING KIT MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 290. EUROPE, MIDDLE EAST & AFRICA HLA TYPING KIT MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 291. EUROPE, MIDDLE EAST & AFRICA HLA TYPING KIT MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 292. EUROPE, MIDDLE EAST & AFRICA HLA TYPING KIT MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 293. EUROPE, MIDDLE EAST & AFRICA HLA TYPING KIT MARKET SIZE, BY KITS, 2018-2024 (USD MILLION)
TABLE 294. EUROPE, MIDDLE EAST & AFRICA HLA TYPING KIT MARKET SIZE, BY KITS, 2025-2030 (USD MILLION)
TABLE 295. EUROPE, MIDDLE EAST & AFRICA HLA TYPING KIT MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 296. EUROPE, MIDDLE EAST & AFRICA HLA TYPING KIT MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 297. EUROPE, MIDDLE EAST & AFRICA HLA TYPING KIT MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
TABLE 298. EUROPE, MIDDLE EAST & AFRICA HLA TYPING KIT MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2030 (USD MILLION)
TABLE 299. EUROPE, MIDDLE EAST & AFRICA HLA TYPING KIT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 300. EUROPE, MIDDLE EAST & AFRICA HLA TYPING KIT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 301. UNITED KINGDOM HLA TYPING KIT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 302. UNITED KINGDOM HLA TYPING KIT MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 303. UNITED KINGDOM HLA TYPING KIT MARKET SIZE, BY NEXT GEN SEQUENCING, 2018-2024 (USD MILLION)
TABLE 304. UNITED KINGDOM HLA TYPING KIT MARKET SIZE, BY NEXT GEN SEQUENCING, 2025-2030 (USD MILLION)
TABLE 305. UNITED KINGDOM HLA TYPING KIT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 306. UNITED KINGDOM HLA TYPING KIT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 307. UNITED KINGDOM HLA TYPING KIT MARKET SIZE, BY ORGAN TRANSPLANTATION, 2018-2024 (USD MILLION)
TABLE 308. UNITED KINGDOM HLA TYPING KIT MARKET SIZE, BY ORGAN TRANSPLANTATION, 2025-2030 (USD MILLION)
TABLE 309. UNITED KINGDOM HLA TYPING KIT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 310. UNITED KINGDOM HLA TYPING KIT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 311. UNITED KINGDOM HLA TYPING KIT MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 312. UNITED KINGDOM HLA TYPING KIT MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 313. UNITED KINGDOM HLA TYPING KIT MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2024 (USD MILLION)
TABLE 314. UNITED KINGDOM HLA TYPING KIT MARKET SIZE, BY HOSPITALS & CLINICS, 2025-2030 (USD MILLION)
TABLE 315. UNITED KINGDOM HLA TYPING KIT MARKET SIZE, BY TRANSPLANT CENTERS, 2018-2024 (USD MILLION)
TABLE 316. UNITED KINGDOM HLA TYPING KIT MARKET SIZE, BY TRANSPLANT CENTERS, 2025-2030 (USD MILLION)
TABLE 317. UNITED KINGDOM HLA TYPING KIT MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 318. UNITED KINGDOM HLA TYPING KIT MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 319. UNITED KINGDOM HLA TYPING KIT MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 320. UNITED KINGDOM HLA TYPING KIT MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 321. UNITED KINGDOM HLA TYPING KIT MARKET SIZE, BY KITS, 2018-2024 (USD MILLION)
TABLE 322. UNITED KINGDOM HLA TYPING KIT MARKET SIZE, BY KITS, 2025-2030 (USD MILLION)
TABLE 323. UNITED KINGDOM HLA TYPING KIT MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 324. UNITED KINGDOM HLA TYPING KIT MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 325. UNITED KINGDOM HLA TYPING KIT MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
TABLE 326. UNITED KINGDOM HLA TYPING KIT MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2030 (USD MILLION)
TABLE 327. GERMANY HLA TYPING KIT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 328. GERMANY HLA TYPING KIT MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 329. GERMANY HLA TYPING KIT MARKET SIZE, BY NEXT GEN SEQUENCING, 2018-2024 (USD MILLION)
TABLE 330. GERMANY HLA TYPING KIT MARKET SIZE, BY NEXT GEN SEQUENCING, 2025-2030 (USD MILLION)
TABLE 331. GERMANY HLA TYPING KIT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 332. GERMANY HLA TYPING KIT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 333. GERMANY HLA TYPING KIT MARKET SIZE, BY ORGAN TRANSPLANTATION, 2018-2024 (USD MILLION)
TABLE 334. GERMANY HLA TYPING KIT MARKET SIZE, BY ORGAN TRANSPLANTATION, 2025-2030 (USD MILLION)
TABLE 335. GERMANY HLA TYPING KIT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 336. GERMANY HLA TYPING KIT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 337. GERMANY HLA TYPING KIT MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 338. GERMANY HLA TYPING KIT MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 339. GERMANY HLA TYPING KIT MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2024 (USD MILLION)
TABLE 340. GERMANY HLA TYPING KIT MARKET SIZE, BY HOSPITALS & CLINICS, 2025-2030 (USD MILLION)
TABLE 341. GERMANY HLA TYPING KIT MARKET SIZE, BY TRANSPLANT CENTERS, 2018-2024 (USD MILLION)
TABLE 342. GERMANY HLA TYPING KIT MARKET SIZE, BY TRANSPLANT CENTERS, 2025-2030 (USD MILLION)
TABLE 343. GERMANY HLA TYPING KIT MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 344. GERMANY HLA TYPING KIT MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 345. GERMANY HLA TYPING KIT MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 346. GER

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this HLA Typing Kit Market report include:
  • Thermo Fisher Scientific, Inc.
  • Immucor, Inc.
  • Bio-Rad Laboratories, Inc.
  • QIAGEN N.V.
  • GenDx B.V.
  • Illumina, Inc.
  • Roche Holding AG
  • BGI Genomics Co., Ltd.
  • Abbott Laboratories
  • DiaSorin S.p.A.

Related Topics

Related Reports

HLA Typing Market by Product Type (Instruments, Reagents & Consumables, Services), Technology (Molecular Assays, Non-Molecular Assays), Application, End User - Global Forecast 2025-2030 - Product Image

HLA Typing Market by Product Type (Instruments, Reagents & Consumables, Services), Technology (Molecular Assays, Non-Molecular Assays), Application, End User - Global Forecast 2025-2030

  • Report
  • 183 Pages
  • Global
From
HLA Typing for Transplant Market by Product Type (Instruments, Reagents & Consumables, Software), Technology (Molecular Assays, Non-molecular Assays), Transplant Type, Application, End user - Global Forecast 2025-2030 - Product Image

HLA Typing for Transplant Market by Product Type (Instruments, Reagents & Consumables, Software), Technology (Molecular Assays, Non-molecular Assays), Transplant Type, Application, End user - Global Forecast 2025-2030

  • Report
  • 198 Pages
  • Global
From
HLA Typing Market by Technology (PCR (SSO, SSP, Real-time), Sequencing (NGS, Sanger's)), Product (Instruments, Reagents, Software), Application (Donor-recipient Cross-matching, Transfusion, Cancer), End User (Hospitals, Reference Labs) Global Forecasts to 2030 - Product Image

HLA Typing Market by Technology (PCR (SSO, SSP, Real-time), Sequencing (NGS, Sanger's)), Product (Instruments, Reagents, Software), Application (Donor-recipient Cross-matching, Transfusion, Cancer), End User (Hospitals, Reference Labs) Global Forecasts to 2030

  • Report
  • 267 Pages
  • Global
From
HLA Typing for Transplant Market by Technology, Product, Application, Type, End User - Global Forecast to 2030 - Product Image

HLA Typing for Transplant Market by Technology, Product, Application, Type, End User - Global Forecast to 2030

  • Report
  • 261 Pages
  • Global
From
HLA Typing for Transplant Market - Global Industry Size, Share, Trends, Opportunity & Forecast, 2019-2029F - Product Image

HLA Typing for Transplant Market - Global Industry Size, Share, Trends, Opportunity & Forecast, 2019-2029F

  • Report
  • 185 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.